Castleview Partners, LLC Novartis Ag Transaction History

Castleview Partners, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 01, 2023	SELL	$75.55 - $92.52 $7,555 - $9,252	-100 Reduced 56.5%	77 $6,000
Q3 2022 Nov 10, 2022	BUY	$74.61 - $87.26 $2,760 - $3,228	37 Added 26.43%	177 $13,000
Q2 2022 Aug 17, 2022	SELL	$80.52 - $93.75 $6.98 Million - $8.13 Million	-86,672 Reduced 99.84%	140 $11,000
Q2 2022 Aug 16, 2022	BUY	$80.52 - $93.75 $6.91 Million - $8.04 Million	85,785 Added 8352.97%	86,812 $7.34 Million
Q1 2022 May 16, 2022	BUY	$80.11 - $90.62 $82,272 - $93,066	1,027 New	1,027 $90,000
Q4 2021 Feb 17, 2022	SELL	$79.7 - $88.13 $67,745 - $74,910	-850 Closed	0 $0
Q2 2021 Aug 17, 2021	BUY	$85.24 - $94.15 $72,454 - $80,027	850 New	850 $78,000

1,437

133M

1.12M

1.83M

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $223B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

Get notified when there are updates to the investment portfolio of Castleview Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Castleview Partners, LLC with notifications on news.